Published in Lab Invest on January 01, 2010
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. J Clin Oncol (2008) 3.34
Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol (2006) 2.71
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol (2008) 2.68
Transforming the architecture of compound eyes. Nature (2006) 2.47
The metabolic syndrome: A high-risk state for cancer? Am J Pathol (2006) 2.46
The Zuker collection: a resource for the analysis of autosomal gene function in Drosophila melanogaster. Genetics (2004) 2.14
A canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal model. Mol Ther (2003) 1.86
Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning. AJR Am J Roentgenol (2004) 1.76
Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol (2005) 1.76
Loss of primary cilia upregulates renal hypertrophic signaling and promotes cystogenesis. J Am Soc Nephrol (2011) 1.75
Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med (2007) 1.67
Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury. Am J Respir Crit Care Med (2008) 1.61
Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol (2008) 1.58
Desmoplastic fibroma of the jaw: a case report and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2006) 1.45
Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes (2009) 1.42
Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat (2007) 1.41
Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood. Lab Invest (2013) 1.41
Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells. J Immunol (2012) 1.36
Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations. Am J Clin Pathol (2002) 1.30
Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses. Mol Ther (2002) 1.28
Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer. Gastroenterology (2003) 1.28
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. J Clin Oncol (2012) 1.27
Involvement of vitronectin in lipopolysaccaride-induced acute lung injury. J Immunol (2007) 1.26
The Bioenergetic Health Index: a new concept in mitochondrial translational research. Clin Sci (Lond) (2014) 1.25
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. J Clin Oncol (2002) 1.22
A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases. Clin Cancer Res (2010) 1.21
The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma. J Neurosurg (2006) 1.21
LRRK2 secretion in exosomes is regulated by 14-3-3. Hum Mol Genet (2013) 1.15
Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Exp Dermatol (2008) 1.14
Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity. Clin Cancer Res (2003) 1.14
A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer. Gynecol Oncol (2013) 1.10
Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome: a case report emphasizing the cytological and cytogenetic findings. Hum Pathol (2003) 1.10
E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas. Am J Clin Pathol (2009) 1.10
Percutaneous management of ischemic complications in patients with type-B aortic dissection. J Vasc Interv Radiol (2003) 1.09
Mutation of the photoreceptor specific homeodomain gene Pph13 results in defects in phototransduction and rhabdomere morphogenesis. Development (2003) 1.09
p53 modulation as a therapeutic strategy in gastrointestinal stromal tumors. PLoS One (2012) 1.08
Cytogenetics and molecular biology of osteosarcoma. Lab Invest (2002) 1.08
Small cell tumors of bone. Adv Anat Pathol (2010) 1.05
Striking pathology gold: a singular experience with daily reverberations: sinonasal hemangiopericytoma (glomangiopericytoma) and oncogenic osteomalacia. Head Neck Pathol (2012) 1.05
Role of oxygen availability in CFTR expression and function. Am J Respir Cell Mol Biol (2008) 1.05
Evaluation of the LIAISON chemiluminescence immunoassay for diagnosis of syphilis. Clin Vaccine Immunol (2007) 1.04
A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer. Clin Cancer Res (2012) 1.04
MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration. Cancer (2003) 1.03
An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropism. Virology (2004) 1.02
Solid pseudopapillary tumor of the pancreas: a review of salient clinical and pathologic features. Adv Anat Pathol (2008) 1.01
Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression. Cancer Res (2003) 0.99
Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control. Breast Cancer Res Treat (2007) 0.99
Microdissection of histologic sections: past, present, and future. Adv Anat Pathol (2002) 0.99
Transgenic expression of n-3 fatty acid desaturase (fat-1) in C57/BL6 mice: Effects on glucose homeostasis and body weight. J Cell Biochem (2009) 0.98
Preserving cell shape under environmental stress. Nature (2008) 0.98
Productive replication of human adenovirus type 5 in canine cells. J Virol (2005) 0.97
Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo. Int J Oncol (2005) 0.97
A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group. Front Oncol (2013) 0.97
Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways. Cancer Res (2013) 0.96
Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol (2004) 0.96
alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression. Lab Invest (2007) 0.95
Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo. Clin Cancer Res (2008) 0.95
Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds. J Mol Med (Berl) (2007) 0.95
LL-37 as a therapeutic target for late stage prostate cancer. Prostate (2010) 0.95
Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis. Virology (2004) 0.94
Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses. J Thorac Oncol (2006) 0.93
A fiber-modified mesothelin promoter-based conditionally replicating adenovirus for treatment of ovarian cancer. Clin Cancer Res (2008) 0.93
Primary omental haemangiopericytoma. BMJ Case Rep (2011) 0.93
Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system. Breast Cancer Res (2005) 0.92
Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-L-fucose moieties. Int J Oncol (2008) 0.92
Regeneration of pancreatic non-β endocrine cells in adult mice following a single diabetes-inducing dose of streptozotocin. PLoS One (2012) 0.92
Development of an optimized conditionally replicative adenoviral agent for ovarian cancer. Int J Oncol (2008) 0.91
Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis. Mol Ther (2008) 0.91
Inter-patient variation in efficacy of five oncolytic adenovirus candidates for ovarian cancer therapy. J Gene Med (2004) 0.91
The natural history of a novel, systemic, disseminated model of syngeneic mouse B-cell lymphoma. Leuk Lymphoma (2005) 0.91
Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer. Mol Imaging (2009) 0.90
Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy. Clin Cancer Res (2010) 0.90
Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer. J Hematol Oncol (2011) 0.89
Solitary glomus tumor recurring as multiple glomus tumors. Skeletal Radiol (2012) 0.89
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. Clin Cancer Res (2009) 0.89
The emerging importance of α-L-fucose in human breast cancer: a review. Am J Transl Res (2011) 0.89
WASp is required for the correct temporal morphogenesis of rhabdomere microvilli. J Cell Biol (2004) 0.89
Mechanisms modulating inflammatory osteolysis: a review with insights into therapeutic targets. Pathol Res Pract (2008) 0.89
Nicotine exposure and the progression of chronic kidney disease: role of the α7-nicotinic acetylcholine receptor. Am J Physiol Renal Physiol (2012) 0.88
Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma. Int J Oncol (2006) 0.88
Cell surface associated alpha-L-fucose moieties modulate human breast cancer neoplastic progression. Pathol Oncol Res (2008) 0.88
Evaluation of tissue-specific promoters in carcinomas of the cervix uteri. J Gene Med (2004) 0.88
Chondromyxoid fibroma of the cervical spine: case report. Neurosurgery (2002) 0.87
Optimal molecular profiling of tissue and tissue components: defining the best processing and microdissection methods for biomedical applications. Mol Biotechnol (2005) 0.87
Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer. Clin Cancer Res (2009) 0.87
A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway. Clin Cancer Res (2007) 0.87
Administration of a conditionally replicative oncolytic canine adenovirus in normal dogs. Cancer Biother Radiopharm (2006) 0.87
Recommendations for the reporting of bone tumors. Association of Directors of Anatomic and Surgical Pathology. Hum Pathol (2004) 0.87
Complex analysis of a recurrent pleomorphic hyalinizing angiectatic tumor of soft parts. Hum Pathol (2011) 0.87
Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice. Clin Exp Metastasis (2009) 0.86
p38 MAPK as a potential therapeutic target for inflammatory osteolysis. Adv Anat Pathol (2007) 0.86
Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system. Cancer Biol Ther (2005) 0.86
Intracranial metastasis from synovial sarcoma. Orthopedics (2008) 0.86
Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma. Mol Cancer Res (2013) 0.86
Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs. Ann Diagn Pathol (2010) 0.86
Syndecan-1 overexpression is associated with nonluminal subtypes and poor prognosis in advanced breast cancer. Am J Clin Pathol (2013) 0.85
Aggressive osteoblastoma: a case report involving a unique chromosomal aberration. Int J Surg Pathol (2008) 0.85
Prosthetic implant associated sarcomas: a case report emphasizing surface evaluation and spectroscopic trace metal analysis. Ann Diagn Pathol (2003) 0.85